InsideTrading SEC Form 4 insider trades

Stocks

IMNM Immunome Inc.

Healthcare · Market cap: $2.1B

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $0 2022-Q2: bought $0, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $0 2023-Q1: bought $0, sold $0 2023-Q2: bought $0, sold $0 2023-Q3: bought $0, sold $0 2023-Q4: bought $1.2M, sold $0 2024-Q1: bought $0, sold $0 2024-Q2: bought $1.4M, sold $0 2024-Q3: bought $97.6K, sold $279.3K 2024-Q4: bought $1.3M, sold $0 2025-Q1: bought $2.4M, sold $0 2025-Q2: bought $46.9K, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $1.5M, sold $8.3M 2026-Q1: bought $544.3K, sold $1.3M 2026-Q2: bought $307.8K, sold $6.2M 2026-Q3: bought $0, sold $11.7M 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $2.4M) Sold, below the line (largest quarter $11.7M)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$0
2022-Q2$0$0
2022-Q3$0$0
2022-Q4$0$0
2023-Q1$0$0
2023-Q2$0$0
2023-Q3$0$0
2023-Q4$1.2M$0
2024-Q1$0$0
2024-Q2$1.4M$0
2024-Q3$97.6K$279.3K
2024-Q4$1.3M$0
2025-Q1$2.4M$0
2025-Q2$46.9K$0
2025-Q3$0$0
2025-Q4$1.5M$8.3M
2026-Q1$544.3K$1.3M
2026-Q2$307.8K$6.2M
2026-Q3$0$11.7M
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$8.8M25 buy days
Sold$27.8M23 sell days
Net insider flow-$19.0Mnet selling · 5 years
Latest trade2026-09-11Higgins Jack
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-09-11 Sell Higgins Jack Other C-suite 13,200 $25.32 $334.2K 1
2026-08-12 Sell Barchas Isaac Director 11,048 $27.25 $301.1K 1
2026-08-11 Sell Barchas Isaac Director 62,291 $26.23 $1.6M 1
2026-08-10 Sell Barchas Isaac Director 10,125 $26.07 $264.0K 1
2026-08-07 Sell Barchas Isaac Director 15,248 $26.06 $397.4K 1
2026-08-06 Sell Barchas Isaac Director 20,840 $26.06 $543.1K 1
2026-08-04 Sell Horn Kinney Other C-suite 90,616 $25.09 $2.3M 1
2026-07-07 Sell Barchas Isaac Director 16,906 $24.20 $409.1K 1
2026-07-07 Sell Horn Kinney Other C-suite 1,092 $25.00 $27.3K 1
2026-07-06 Sell Barchas Isaac Director 83,094 $24.11 $2.0M 1
2026-07-02 Sell Barchas Isaac Director 100,000 $22.59 $2.3M 2
2026-07-02 Sell Lechleider Robert Other C-suite 55,000 $22.62 $1.2M 3
2026-06-30 Sell Barchas Isaac Director 101,050 $21.12 $2.1M 1
2026-06-25 Sell Lechleider Robert Other C-suite 55,000 $19.85 $1.1M 2
2026-06-15 Sell Rosett Max CFO 60,000 $18.23 $1.1M 1
2026-06-05 Buy BIENAIME JEAN JACQUES Director 10,500 $19.45 $204.3K 3
2026-06-05 Sell BIENAIME JEAN JACQUES Director 10,500 $19.41 $203.8K 2
2026-05-15 Buy BIENAIME JEAN JACQUES Director 5,000 $20.70 $103.5K 1
2026-04-02 Sell Rosett Max CFO 65,000 $21.92 $1.4M 2
2026-04-02 Sell Higgins Jack Other C-suite 9,438 $21.64 $204.2K 1
2026-03-27 Buy SIEGALL CLAY B CEO 25,450 $19.67 $500.6K 1
2026-03-23 Sell WAGENHEIM PHILIP Director 28,200 $20.65 $582.3K 1
2026-03-20 Sell WAGENHEIM PHILIP Director 36,800 $20.47 $753.3K 1
2026-03-11 Buy BIENAIME JEAN JACQUES Director 1,000 $21.55 $21.6K 1
2026-03-10 Buy BIENAIME JEAN JACQUES Director 1,000 $22.12 $22.1K 1
2025-12-30 Buy SIEGALL CLAY B CEO 4,729 $21.15 $100.0K 1
2025-12-22 Sell Barchas Isaac Director 383,200 $21.74 $8.3M 2
2025-12-19 Buy Tsai Philip Other C-suite 10,000 $20.49 $204.9K 1
2025-12-19 Buy SIEGALL CLAY B CEO 7,278 $20.48 $149.1K 1
2025-12-18 Buy SIEGALL CLAY B CEO 46,511 $21.50 $1,000.0K 1
2025-06-03 Buy BIENAIME JEAN JACQUES Director 5,000 $9.38 $46.9K 1
2025-03-26 Buy SIEGALL CLAY B CEO 137,100 $7.29 $999.5K 1
2025-03-25 Buy BIENAIME JEAN JACQUES Director 7,800 $7.78 $60.7K 1
2025-03-24 Buy Tsai Philip Other C-suite 12,300 $8.42 $103.6K 1
2025-03-24 Buy BIENAIME JEAN JACQUES Director 7,000 $8.21 $57.5K 1
2025-01-31 Buy SIEGALL CLAY B CEO 150,000 $7.75 $1.2M 1
2024-11-22 Buy SIEGALL CLAY B CEO 33,943 $9.78 $332.0K 1
2024-11-21 Buy SIEGALL CLAY B CEO 66,057 $9.54 $630.2K 1
2024-11-21 Buy Tsai Philip Other C-suite 21,000 $9.43 $198.0K 1
2024-11-21 Buy Lechleider Robert Other C-suite 15,805 $9.48 $149.8K 1
2024-09-19 Sell Rosett Max CFO 14,380 $16.01 $230.2K 1
2024-08-16 Buy BIENAIME JEAN JACQUES Director 7,000 $13.94 $97.6K 1
2024-08-15 Sell Higgins Jack Other C-suite 3,524 $13.93 $49.1K 1
2024-05-21 Buy SIEGALL CLAY B CEO 20,434 $13.78 $281.6K 1
2024-05-21 Buy BIENAIME JEAN JACQUES Director 2,000 $13.57 $27.1K 1
2024-05-20 Buy SIEGALL CLAY B CEO 79,566 $13.91 $1.1M 1
2023-10-02 Buy SIEGALL CLAY B CEO 169,204 $5.91 $1,000.0K 1
2023-10-02 Buy Turner Bruce Other C-suite 42,300 $5.91 $250.0K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
Barchas Isaac Director $0 $18.3M 2026-08-12
SIEGALL CLAY B CEO $7.3M $0 2026-03-27
Rosett Max CFO $0 $2.7M 2026-06-15
Lechleider Robert Other C-suite $149.8K $2.3M 2026-07-02
Horn Kinney Other C-suite $0 $2.3M 2026-08-04
WAGENHEIM PHILIP Director $0 $1.3M 2026-03-23
BIENAIME JEAN JACQUES Director $641.2K $203.8K 2026-06-05
Higgins Jack Other C-suite $0 $587.6K 2026-09-11
Tsai Philip Other C-suite $506.5K $0 2025-12-19
Turner Bruce Other C-suite $250.0K $0 2023-10-02

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2025-03-24 → 2025-03-26 3 $1.2M 62 +18.0% (+12.9% raw)+10.2% (+15.4% raw)+34.3% (+52.5% raw) closed
2024-11-21 → 2024-11-22 3 $1.3M 63 +6.3% (0.0% raw)-4.5% (-15.3% raw)-6.4% (-21.1% raw) closed
2021-05-24 → 2021-05-26 5 $1.6M 69 -14.6% (-12.1% raw)-30.6% (-32.6% raw)-29.5% (-26.1% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.